Different scaling and root planing strategies in Turkish patients with aggressive periodontitis: A randomized controlled clinical trial.


Mamaklioglu D., Karched M., KURU L., Kuru B., Asikainen S., DOĞAN B.

International journal of dental hygiene, cilt.20, sa.2, ss.347-363, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 20 Sayı: 2
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1111/idh.12592
  • Dergi Adı: International journal of dental hygiene
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.347-363
  • Anahtar Kelimeler: aggressive periodontitis, bacteria, interleukin-1 beta, interleukin-17, periodontal debridement, FULL-MOUTH DISINFECTION, EARLY-ONSET PERIODONTITIS, PERI-IMPLANT DISEASES, ONE-STAGE, ULTRASONIC DEBRIDEMENT, CREVICULAR FLUID, CHRONIC ADULT, TH17 CELLS, THERAPY, CLASSIFICATION
  • Marmara Üniversitesi Adresli: Evet

Özet

Objectives The aim of this study was to compare clinical, cytokine and microbiological responses after quadrant-based scaling and root planing (Q-SRP), full-mouth SRP (FM-SRP) and full-mouth disinfection (FMD) in patients with generalized aggressive periodontitis (GAgP), which is currently termed as generalized stage-III and grade-C periodontitis. Methods Forty-two patients with GAgP were randomly assigned into groups as Q-SRP, FM-SRP or FMD with chlorhexidine. Clinical parameters were recorded, and gingival crevicular fluid (GCF) and subgingival plaque samples were collected at baseline, 3 and 6 months after treatment. GCF levels of interleukin (IL)-1 beta and IL-17 were analysed using ELISA. Quantities of six bacterial species were determined using qPCR. Results Clinical parameters improved significantly in all groups at 3 and 6 months (p < 0.05). Percentage of sites with probing depth >6 mm was lower in the FMD than Q-SRP group at 3 and 6 months (p < 0.05). FMD showed significantly higher percentage of pocket closure compared with Q-SRP and FM-SRP at both 3 and 6 months after treatment (p < 0.05). The IL-1 beta levels decreased only in the FMD group (p < 0.05), whereas no changes were found in IL-17 levels in any group. The levels of five out of six bacterial species decreased at 3 and/or 6 months only in the FMD group (p < 0.05). Conclusions The FMD treatment appears to offer superior outcome than Q-SRP and could be the first choice for patients with GAgP.